FdaApplication
ANDA 210619
Identifiers
- fda_app_no: ANDA210619
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2019-02-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRIENTINE HYDROCHLORIDE | TRIENTINE HYDROCHLORIDE | 250MG | CAPSULE;ORAL |
1 product